Low frequency of drug-drug interactions (DDIs) with the novel all oral antivirals elbasvir (EBV) and grazoprevir (GRZ) in patients with HCV genotype 1 infection in German real-world

2016 ◽  
Vol 54 (08) ◽  
Author(s):  
P Buggisch ◽  
H Löhr ◽  
G Teuber ◽  
H Steffens ◽  
M Kraus ◽  
...  
Keyword(s):  
Drug Interactions ◽  
Real World ◽  
Low Frequency ◽  
The Novel ◽  
Genotype 1 ◽  
Hcv Genotype ◽  
Hcv Genotype 1

Low frequency of drug-resistant virus did not affect the therapeutic efficacy in daclatasvir plus asunaprevir therapy in patients with chronic HCV genotype 1 infection

2015 ◽  
Vol 21 (1) ◽  
pp. 37-44 ◽  
Author(s):  
Hideaki Kinugasa ◽  
Fusao Ikeda ◽  
Kouichi Takaguchi ◽  
Chizuru Mori ◽  
Takehiro Matsubara ◽  
...  
Keyword(s):  
Therapeutic Efficacy ◽  
Low Frequency ◽  
Drug Resistant ◽  
Resistant Virus ◽  
Genotype 1 ◽  
Hcv Genotype ◽  
Hcv Genotype 1 ◽  
Chronic Hcv ◽  
Drug Resistant Virus

scholarly journals Daclatasvir plus Asunaprevir Treatment for Real-World HCV Genotype 1-Infected Patients in Japan

2016 ◽  
Vol 13 (6) ◽  
pp. 418-423 ◽  
Author(s):  
Tatsuo Kanda ◽  
Shin Yasui ◽  
Masato Nakamura ◽  
Eiichiro Suzuki ◽  
Makoto Arai ◽  
...  
Keyword(s):  
Real World ◽  
Genotype 1 ◽  
Hcv Genotype ◽  
Hcv Genotype 1

scholarly journals Effectiveness of Simeprevir Plus Sofosbuvir, With or Without Ribavirin, in Real-World Patients With HCV Genotype 1 Infection

2016 ◽  
Vol 150 (2) ◽  
pp. 419-429 ◽  
Author(s):  
Mark S. Sulkowski ◽  
Hugo E. Vargas ◽  
Adrian M. Di Bisceglie ◽  
Alexander Kuo ◽  
K. Rajender Reddy ◽  
...  
Keyword(s):  
Real World ◽  
Genotype 1 ◽  
Hcv Genotype ◽  
Hcv Genotype 1
Sign in / Sign up

Export Citation Format

Share Document